CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy
Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://cnw.fm/XL0hJ). As scientific evidence supporting…